Who we are
About us
Our values
Environmental, social & governance
Therapeutic areas
What we do
Consulting (Acsel Health)
HEOR & market access
Scientific communications
Creative communications
Patient engagement
Insights
News & Events
Join us
Careers
Reasons to join
Contact us
Menu
Menu
What we do /
Publications library
Publications library
Publications
Service Areas
All
Health Economic Modeling & Meta-analysis
Patient-Centered outcomes
Real-world Evidence & Data Analytics
Market Access Strategy
Therapeutic Areas
All
Cardiology
Dermatology
Endocrinology and metabolism
Gastroenterology
Hematology
Immunology
Infectious diseases and vaccines
Mental Health
Neurology
Oncology
Ophthalmology
Other
Pulmonology and respiratory
Rare disease
Rheumatology
Substance use disorders
Urology
Women's health
Sort by
Newest to Oldest
Oldest to Newest
A Review of the 2024 Quantitative Evidence Synthesis Guidelines: Key Updates and Future Directions
Authors:
Sonja Kroep and Dorothea Heldt
The Rise of Artificial Intelligence for Evidence Synthesis and Analysis
Authors:
Emanuele Arcà, Nick Halfpenny & Elisabeth Fenwick
Clinical and economic value of a biosimilar portfolio to stakeholders: An integrative literature review
Authors:
G E Fox, M Bernauer, J M Stephens, B Jackson, J A Roth, A Shelbaya
Meet Karen King, an OPEN Health Scientific Trailblazer
Authors:
Meet Sophie Tsai, MD, MBA, MHS, an OPEN Health Scientific Trailblazer
Authors:
Meet Eleanor Bush, an OPEN Health Scientific Trailblazer
Authors:
Building Bridges to Accelerate Innovation in Medical Affairs: Highlights of the Maps 2024 Americas Annual Meeting
Authors:
Lauren Stutzbach, Associate Director, Medical Strategy
ISPOR Europe 2023
Authors:
ISPOR US 2023
Authors:
Health Technology Assessment International (HTAi)
Authors:
Real-world use of Ubrogepant as acute treatment for migraine with an anti-calcitonin gene-related peptide monoclonal antibody: results from COURAGE
Authors:
R B Lipton, J Contreras-De Lama, D Serrano, E Engstrom, N D Ayasse, W Poh, F Cadiou, A M Adams
Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials
Authors:
R A Dobra, M Boeri, S Elborn, F Kee, S Madge, J C Davies
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
Authors:
OPEN Health presenting innovative research on capitalizing data for patient access at ISPOR Europe
Authors:
Day in the life of a Principal Medical Writer
Authors:
Psychosocial health modifies associations between HPA-axis function and brain structure in older age
Authors:
I F van der Velpen, M de Feijter, R Raina, F Özel, M Perry, M A Ikram, M W Vernooij, A I Luik
The Challenges of Modeling Rare Diseases and Making the Best Use of Limited Data
Authors:
Martijn Simons, Craig Bennison and Claire Simons
OPEN Health Announces a New Team of Experts Will Lead Its HEOR & Market Access Scientific Office
Authors:
Highlights from the Patient Centricity and Engagement Conference
Authors:
Jasmine Malone, Head of Patient Content
ISMPP 2023 Parallel Session: Developing Patient-Accessible Publication Extenders: Key Stakeholder Perspectives
Authors:
Anna Frangou, PhD, Medical Associate; Julianne Hatfield, PhD, Associate Medical Director; Seán T. Anderson, PhD, Associate Medical Director
Breaking Down Barriers to “Patient-First” Approaches — ISMPP Panel Discussion Summary
Authors:
Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocar
Authors:
D Lin, H Nguyen, R Shah, Y Qiao, J Hartman, R Sugarman
The Patient Journey Map – Utilizing Insights and Analysis to Deliver Meaningful Support
Authors:
Including the Patient Voice in Publication Planning and Development
Authors:
Expanding the Role of Medical Affairs: A Focus on Omnichannel Execution, Artificial Intelligence, and Health Equality
Authors:
Celebrating OPEN Health’s Patient Centricity Year Book
Authors:
Gavin Jones
3 Pillars of Effective Patient Community/ Pharma Collaboration
Authors:
Variation in access to specialist services for neurosurgical procedures in adults with epilepsy in England, a cohort study
Authors:
J Murphy, G C Hall, F Barion, V Danielson, M Dibué, J Wallace, M Alexander, S Beecroft, A Sen
Quality-adjusted time without symptoms or toxicity: analysis of axicabtagene ciloleucel versus standard of care in patients with relapsed/refractory large b-cell lymphoma: Q-TWiST analysis of axi-cel versus standard of care
Authors:
M J Kersten, Y Qiao, R Shah, C Solem, J T Snider, C To, P Cheng, C Spooner, M-A Perales
A probabilistic cost-effectiveness analysis of Venetoclax and Obinutuzumab as a first-line therapy in chronic lymphocytic leukemia in Canada
Authors:
A Chatterjee, G van de Wetering, R Goeree, C Owen, A M Desbois, S Barakat, B S Manzoor, K Sail
Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanoma
Authors:
R Frazer, A Gupta, C Herbert, M Payne, S Diaz-Mendoza, S-A Vincent, E Kovaleva
Harness the Power of HEOR Writing
Authors:
Beth Lesher and Larry Radican
Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences
Authors:
P A Powell, M Karimi, D Rowen, N Devlin, B van Hout, J E Brazier
OPUF: Getting Personal About Preferences
Authors:
Marieke Heisen
Continued posttrial benefits of Buprenorphine extended release: RECOVER study findings
Authors:
B Boyett, V R Nadipelli, C T Solem, H Chilcoat, W K Bickel, W Ling
Innovation in Cancer Diagnosis and Treatment
Authors:
Emma Winter, Head Medical and Scientific Services and Rosie Lobley, Communications Manager
The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations
Authors:
S D Goldenberg, S Brown, L Edwards, D Gnanarajah, P Howard, D Jenkins, D Nayar, M Pasztor, S Oliver, T Planche, J A T Sandoe, P Wade, L Whitney
Multiple treatment comparison in narcolepsy: a network meta-analysis-methodological concerns
Authors:
S J Snedecor, G Mayer, M J Thorpy, Y Dauvilliers
Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States
Authors:
E Armbrecht, A Shah, P Schepman, R Shah, E Pappadopulos, R Chambers, J Stephens, S Haider, R S McIntyre
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
Authors:
G Byttebier, L Belmans, M Alexander, B E H Saxberg, B De Spiegeleer, A De Spiegeleer, N Devreker, J T Van Praet, K Vanhove, R Reybrouck, E Wynendaele, D S Fedson
Cancer Inequity: What is it and what can be done?
Authors:
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain
Authors:
J-Á Hernández-Rivas, M Arnao, J M A Pérez, A Rubio, E G García, D de Miguel, D Cherepanov, D Romanus, K Verleger, C Johnson, S L Corman, M Grande, E P Persona
A quality-adjusted survival time without symptom or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy
Authors:
C T Solem, T J Bell, Y Kwon, J C Cappelleri, C Johnson, H Bhattacharyya, C J Hoang, J E Cortes
Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US
Authors:
A M Khanani, P U Dugel, J A Haller, A L Wagner, B Lescrauwaet, R Schmidt, C Bennison
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
Authors:
M Barbier, N Durno, C Bennison, M Örtli, C Knapp, M Schwenkglenks
Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to- high risk acute coronary syndrome and planned percutaneous coronary intervention
Authors:
V Patel, F-J Lin, O Ojo, S Rao, S Yu, L Zhan, D R Touchette
Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey
Authors:
R Shah, C Nwankwo, Y Kwon, S L Corman
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling
Authors:
R D Ballal, M F Botteman, I Foley, J M Stephens, C T Wilke, A V Joshi
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study
Authors:
H Malik, A Z Khan, D P Berry, I C Cameron, I Pope, D Sherlock, S Helmy, B Byrne, M Thompson, A Pulfer, B Davidson
Measuring meaningful benefit-risk tradeoffs to promote patient-focused drug development in Prader-Willi syndrome: a discrete-choice experiment
Authors:
J-H Tsai, N L Crossnohere, T Strong, J F P Bridges
Patient-reported complications, symptoms, and experiences of living with x-linked hypophosphatemia across the life-course
Authors:
M Cheung, A J Rylands, A Williams, K Bailey, J Bubbear
Quality-Adjusted survival with combination nab-paclitaxel+gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis
Authors:
M Reni, Y Wan, C Solem, S Whiting, X Ji, M Botteman
The importance of multidisciplinary collaboration for omnichannel customer engagement
Authors:
Technology Solutions Team
Why recognizing Juneteenth is more important now than ever
Authors:
The ESG Team
Reflections on the MAPS 2022 EMEA Annual Meeting
Authors:
Bella Santa Cruz, Integration & Partnerships Director
Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation
Authors:
J Radford, P McKay, R Malladi, R Johnson, A Bloor, F Percival, A Sureda, K S Peggs
A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China
Authors:
X Yan, H-T Hu, S Liu, Y-H Sun, X Gao
Unlock Possibilities with OPEN Health after ISPOR US 2022
Authors:
ISMPP 2022: Omnichannel, the first step for future-ready medical communications?
Authors:
Trish Shepherd, Global Head of Business Development
Reflections on the MAPS 2022 Global Annual Meeting
Authors:
Dana Franznick, Senior Director, Medical Strategy
MAPS 2022: Omnichannel is a popular topic for Medical Affairs, with many looking to the experts on how to make it work
Authors:
Continuation of systemic treatments and outcomes for patients with chronic graft-versus-host disease in the USA
Authors:
X Huang, N Joshi, L Luo, N Shamseddine, X Gao
Claims Data Analysis of Dosing and Cost of TNF Antagonist
Authors:
N Yan Gu, X Huang, K M Fox, V D Patel, S W Baumgartner, C Chiou
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data
Authors:
V Strand, R Shah, C Atzinger, J Zhou, J Clewell, A Ganguli, N Tundia
Patterns of clinical management of atopic dermatitis in infants and toddlers: A survey of three physician specialties in the united states
Authors:
J M Saavedra, M Boguniewicz, S Chamlin, A Lake, S Nedorost, L A Czerkies, V Patel, M F Botteman, E G Horodniceanu
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
Authors:
Candice Subero
A day in the life of a Senior Account Manager
Authors:
Gabby Santa Cruz, Communications and Connectivity Manager
A day in the life of a Senior Medical Writer
Authors:
Gabby Santa Cruz, Communications and Connectivity Manager
COMMunity: Unifying and recognizing our brilliant people
Authors:
Gabby Santa Cruz, Communications and Connectivity Manager
Results from a cross-sectional, observational study to assess inadequate pain relief in patients with knee and/or hip osteoarthritis in Mexico
Authors:
R Burgos-Vargas, J Aggarwal, K D Johnson, D Ramey, F Lozano, C Macahilig, I Doshi, K Tunceli
Key elements of a real-world evidence generation plan: integration of product support activities
Authors:
A day in the life of a Learning & Development Account Manager
Authors:
Ines Nebi, Marketing Executive
New Policy Updates on Digital Health in the EU: Major Milestones and Critical Policy Points for Artificial Intelligence in Health and Healthcare in the EU
Authors:
Emanuele Arcà
Professor Ben van Hout Honored with ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award, 2020
Authors:
Candice Subero
Lipid management across Europe in the real-world setting: a rapid evidence review
Authors:
V Barrios, J Soronen, A M Carter, A Anastassopoulou
A multicenter, randomized, double-blind, placebo-controlled study of the efficacy, tolerability, and safety of celecoxib oral solution (ELYXYB) in acute treatment of episodic migraine with or without aura
Authors:
R B Lipton, S Munjal, S J Tepper, C Iaconangelo, D Serrano
Announcing Our New Communications CEO, Margot Hannah
Authors:
Candice Subero
Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: The UK TRANSIT Study
Authors:
S McCartney, J O Lindsay, R K Russell, D R Gaya, I Shaw, C Murray, T Finney-Hayward, S Sebastian
The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS
Authors:
T Talbot, A Dangoor, R Shah, J Naik, D Talbot, J F Lester, R Cipelli, M Hodgson, A Patel, M Summerhayes, T Newsom-Davis
Resource use associated with hospitalisations for recurrent Clostridium difficile infection
Authors:
Mark Wilcox, John Coia, Andrew Dodgson, Susan Hopkins, Martin Llewelyn, Chris Settle, Harblas Ahir, Susan Mclain-Smith
21st century state of rheumatoid arthritis management in the UK
Authors:
Ai Lyn Tan, Maya Buch, David O’Reilly, Tom Sheeran, Georgina Nock, Sarang Chitale, Paul Emery
Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study
Authors:
J Sandoe, K Saeed, A Guleri, K Hand, R Dillon, M Allen, A Mayes, F Glen, A Gonzalez-Ruiz
Quality of Life and ability to work in patients at different disease stages of HER2+ breast cancer
Authors:
M Verrill, AM Wardley, J Retzler, AB Smith, D McNicol, S Dando, I Tran, I Leslie, P Schmid
Steroid and antibiotic prescribing rates in UK patients with ulcerative colitis on vedolizumab vs anti-TNF
Authors:
G Parkes, A Akbar, I Beales, M Buckley, T Creed, S Din, N Plevris, N Heggs, S Meadowcroft, M Wallington, A Fraser
End of life secondary care resource use and costs in mycosis fungoides and Sézary Syndrome: An analysis of hospital episode statistics
Authors:
N Muszbek, F Glen, D Heaton, L McNamara
A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA)
Authors:
T Pang, S C Bain, R Neil, A Black, J G Boyle, J Elliott, A Holcombe, K C S Lee, C Mulligan, L Saunders, A Yousseif and M Baxter
Retrospective analysis of the burden of cytomegalovirus disease in immunosuppressed patients after haematopoietic cell transplantation in England
Authors:
M English, Z Hakimi, M Toumi, F Glen, S Oliver, S Aballéa S & S Ferchichi
A Day in the Life of an Associate Market Access Consultant
Authors:
Sarah Webb, associate market access consultant
How should the rare community react to this week’s news from bluebird bio?
Authors:
Gavin Jones, Global Advisor, Rare Disease
Accelerating and sustaining the life of an advanced therapy through rare insight
Authors:
Trish Shepherd, Global Head of Business Development, OPEN Health
Measuring success through digital innovation: how to gather good data to evaluate your training program and track the impact of technological enhancements
Authors:
Briony Frost, Learning & Development Specialist and Dominika Bijos, Senior Learning Designer
Demonstrating the value of gene therapy in rare disease
Authors:
Charlotte Richards, Customer Strategy Director, OPEN Health Evidence and Access
Digital innovations – fabulous or a fad? Where to invest in digital for maximum learning benefit when implementing your training program
Authors:
Nancy Molyneaux, Account Executive and Briony Frost, Learning & Development Specialist
Realizing the ambition of Star Wars Medicine: widely available gene therapies that deliver outcomes
Authors:
Gavin Jones, Global Advisor, Rare Diseases
Why prioritize the patient voice when developing your training program and how can digital innovation help?
Authors:
Nancy Molyneaux, Account Executive and Briony Frost, Learning & Development Specialist
Navigating pathways in rare – key learnings
Authors:
Gavin Jones, Global Advisor, Rare Diseases
Metrics matter: measuring learning impact in healthcare training
Authors:
Briony Frost, Learning & Development Specialist
Technology-driven or technology-enhanced design? How to choose the right digital tools for your training programs and avoid digital fatigue
Authors:
Dominika Bijos, Senior Learning Designer and Briony Frost, Learning & Development Specialist
Forming early partnerships to understand the patient pathway
Authors:
Marie Keetley, Global Business Development Operations Lead
Navigating healthcare professional connectivity in rare
Authors:
Louise Carrington, Global Client Partnerships Director at OPEN Health
Learn how to step forward: analyze your learners’ digital needs and digital literacy to help create better training programs
Authors:
Briony Frost, Learning & Development Specialist
Pride versus acceptance versus tolerance in the workplace
Authors:
Briony Frost, Learning & Development Specialist
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review
Authors:
M C Dubinsky, I Dotan, D T Rubin, M Bernauer, D Patel, R Cheung, I Modesto, M Latymer, L Keefer
Develop team competencies with real-world learning and authentic assessments
Authors:
Nancy Molyneaux, Account Executive and Briony Frost, Learning & Development Specialist
Promoting interactivity, motivation, and engagement in virtual learning
Authors:
Briony Frost, Learning & Development Specialist, Ben Halford, Account Manager, and Aniket Parikh, Senior Medical Writer
Make your training real-world ready and promote the patient voice
Authors:
Briony Frost, Learning Development Specialist, and Sophie Officer-Thorley and Rebecca Case, Senior Account Managers
Bringing data to life: thinking about the ‘so what’
Authors:
Aniket Parikh, Senior Medical Writer
Motivate staff and manage their training with learner journeys
Authors:
Briony Frost, Learning & Development Specialist & Stephen Hare, Senior Account Executive
Collaborate with clients to create excellent content
Authors:
Hannah Bradbury, Associate Medical Writer
Five new approaches to optimize your publication steering committees in a virtual world
Authors:
Cory Hussar, Senior Medical Director
Rare thoughts & outcomes – navigating pathways to better outcomes in rare
Authors:
Gavin Jones, Global Advisor, Rare Disease
How to pick the perfect training program for your healthcare professionals
Authors:
Briony Frost, Learning & Development Specialist
Maximize your training investments with learning and development specialists
Authors:
Briony Frost, Learning & Development Specialist & Hattie Mills, Senior Account Executive
Disruptive listening to better engage patients in research: highlights from the Patients as Partners Europe Virtual Conference
Authors:
Sergio Diaz and Krystallia Pantiri
Improving patient transitions for people living with rare – key learnings
Authors:
Gavin Jones, Global Advisor, Rare Diseases
OPEN Health publishes 2020 rare disease yearbook
Authors:
Shreena Chotai
My first year as an Editor at OPEN Health Medical Communications: Eleanor Star
Authors:
Gabby Santa Cruz
My first year as an Associate Medical Writer at OPEN Health Medical Communications: Shireene Kalbassi
Authors:
Liam O'Hara
A day in the life of an Account Manager Rose-Marie Billington
Authors:
Liam O'Hara
NORD Rare Diseases Breakthrough Summit
Authors:
Gavin Jones
The patient as priority: How can effective internal training contribute to improving patient outcomes?
Authors:
Briony Frost
Cost-utility of all-oral direct-acting antiviral regimens for the treatment of genotype 1 chronic hepatitis C virus-infected patients in Hong Kong
Authors:
M F Yuen, S H Liu, W K Seto, L Y Mak, S L Corman, D C Hsu, M Y K Lee, T K Khan, A Puenpatom
Reflections of a fireside chat from the World Orphan Drug Congress 2020
Authors:
Trish Shepherd
OPEN Health’s virtual reflections on the World Orphan Drug Congress US
Authors:
Gavin Jones
A QTWiST Analysis of Glasdegib Plus Low‐Dose Cytarabine Versus Low‐Dose Cytarabine as Initial Therapy for Acute Myeloid Leukemia in Patients Who Are Not Considered Candidates for Intensive Chemotherapy
Authors:
CT Solem, TJ Bell, Y Kwon, JC Cappelleri, C Johnson, H Bhattacharyya, CJ Hoang, JE Cortes
Candice Subero to Lead Global Marketing for OPEN Health
Authors:
Biljana Vučenović
The RARE Youth Revolution has begun
Authors:
Daisy Marriott and Nicola Miller
Top tips from five years of account management
Authors:
Yurie Oates
Three steps I take for stress-free, successful virtual meetings and events
Authors:
Stacey Osafo
The field team are off the road! What should they do next?
Authors:
Briony Frost
Delivering Medical Communications when travel is restricted: solving the 6 most common problems
Authors:
Louise Carrington and Gemma Allen
Visualising data: Highlights from the 2020 European Meeting of ISMPP
Authors:
Eleanor Raynsford
Mapping the clinical and emotional journey to better understand lived experience
Authors:
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Economic outcomes related to persistence and dosing of celecoxib in patients with osteoarthritis (OA) using a retrospective claims database analysis
Authors:
C Johnson, J Stephens, C Walker, J Cappelleri, A Shelbaya
What is adult learning theory and how can it be used to help maximise your team’s potential?
Authors:
Briony Frost
Empowering and equipping medical affairs teams to embrace an ever-expanding remit
Authors:
Francisca Costa
Why patient engagement really matters
Authors:
Richard Jones
The economic burden of bronchiectasis – known and unknown: a systematic review
Authors:
P C Goeminne, F Hernandez, R Diel, A Filonenko, R Hughes, F Juelich, G M Solomon, A Upton, K Wichmann, W Xu, J D Chalmers
Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study
Authors:
P J Patel, D H Steel, C Hirneis, J Brazier, A Aly, B Lescrauwaet, MeMo Study Group
Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis
Authors:
D F McDermott, R Shah, K Gupte-Singh, J Sabater, L Luo, M Botteman, S Rao, M M Regan, M Atkins
OPEN Health becomes sponsor of MedComms Networking
Authors:
Rob Pilbrow
Deep-vein thrombosis in Europe – burden of illness in relationship to healthcare resource utilization and return to work
Authors:
L H Chuang, B van Hout, A T Cohen, P D Gumbs, S Kroep, R Bauersachs, A K Gitt, M Montreal, S N Willich, G Agnelli
The Impact of Co-Morbidity on the Disease Burden of VTE
Authors:
S Kroep, LH Chuang, A Cohen, P Gumbs, B van Hout, M Monreal, SN Willich, A Gitt, R Bauersachs, G Angelli
Deep vein thrombosis in Europe – health-related quality of life and mortality
Authors:
M Montreal, G Agnelli, L H Chuang, A T Cohen, P D Gumbs, R Bauersachs, P Mismetti, A K Gitt, S Kroep, S N Willich, B van Hout
Spotlight interview: 15 minutes on insights and market research in pharma
Authors:
Neil Rees
OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Authors:
Gavin Jones
Patient journey mapping: exploring the clinical and the emotional journey
Authors:
Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Spotlight interview: 15 minutes on strategic planning in pharma
Authors:
Ian Lee
Spotlight interview: 15 minutes on learning and development
Authors:
Alexander Devine Website has gone live!
Authors:
Sian Salter
The challenges in accessing cannabis-based medicines
Authors:
Isobel Owens
Spotlight interview: 15 minutes on patient engagement in pharma
Authors:
Richard Jones
New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data
Authors:
Feng Y, Devlin NJ, Shah KK, Mulhern B, van Hout B
A quality-adjusted time without symptoms or toxicity (Q-TWIST) analysis of nivolumab versus everolimus in advanced renal cell carcinoma (aRCC)
Authors:
R Shah, M Botteman, C T Solem, L Luo, J Doan, D Cella, R J Motzer
The AI revolution: how artificial intelligence is transforming the healthcare sector
Authors:
Fiona Glen
Looking back at ASCO 2019
Authors:
Sean McGrath
“If You Want To Go Fast, Go Alone. If You Want To Go Far, Go Together”
Authors:
Emily Wigginton
Co-Creating Solutions for Quality Patient Engagement
Authors:
Richard Jones
Recognising World Haemophilia Day
Authors:
Poppy Qualtrough & Sonja Rnic
Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries
Authors:
L H Chuang, P Gumbs, B van Hout, G Agnelli, S Kroep, M Monreal, R Bauersachs, S N Willich, A Gitt, P Mismetti, A Cohen, D Jimenez
The central role of the hospital pharmacist – lessons from EAHP 2019
Authors:
Jenny Feehan
OPEN Health Graduates and the XP Support Group
Authors:
OPEN Health Graduates
The latest in IBD from the European Crohn’s and Colitis Organisation (ECCO) 2019 Congress
Authors:
Jenny Feehan
The Critical Role of Medical Affairs: Getting Fit For the Future
Authors:
Jill Condello
Health state utilities for acute myeloid leukaemia: a time trade-off study
Authors:
N Joshi, M Hensen, S Patel, W Xu, K Lasch, E Stolk
Pathway to Launch Excellence
Authors:
Pulmonary Embolism in Europe – burden of illness in relationship to healthcare resource utilization and return to work
Authors:
S N Willich, L H Chuang, B van Hout, P Gumbs, D Jimenez, S Kroep, R Bauersachs, M Monreal, G Angelli, A Cohen
Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
Authors:
M A Riedl, A Banerji, M E Manning, E Burrell, N Joshi, D Patel, T Machnig, M H Tai, D J Watson.
Medical Resource Utilization and Costs from Subsequent Metastasis in Prostate Cancer (PC) Patients Initially Diagnosed with Locoregional Disease
Authors:
Li, Shore N.; Mehra, M.; Todd, M.; Saadi. R.; Leblay, G.; Griffiths, R.; Aggarwal, J.
Quality-adjusted survival with nab-paclitaxel versus standard paclitaxel in metastatic breast cancer: a Q-TWiST analysis
Authors:
J Cortes, J Perez-Garcia, S Whiting, Y Wan, C Solem, M H Tai, S Margunato-Debay, A Ko, A Fandi, M Botteman
Quality-adjusted outcomes stratified by response in patients with advanced non-small-cell lung cancer receiving first-line nab-paclitaxel/carboplatin or paclitaxel/carboplatin
Authors:
V Hirsh, Y Wan, F J Lin, S Marqunato-Debay, T J Ong, M Botteman, C Langer
Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases
Authors:
M Botteman, V Barghout, J Stephens, J Hay, J Brandman, M Aapro
Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention
Authors:
B M Heeg, R J Peters, M Botteman, B A van Hout
US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host
Authors:
DA Patel, X Gao, JM Stephens, MS Forshag, M Tarallo.
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours
Authors:
J A Carter, A D Joshi, S Kaura, M F Botteman
Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
Authors:
J M Stephens, X Gao, D A Patel, B G Verheggen, A Shelbaya, S Haider
Assessing uncertainties surrounding combined endpoints for use in economic models
Authors:
B M Heeg, B A van Hout
The impact of parenteral nutrition preparation on bloodstream infection risk and costs
Authors:
R S Turpin, C Solem, A Pontes-Arruda, M Sanon, S Mehta, F Xiaoqing Liu, M Botteman.
Cost of treatment in a US commercially insured, HIV-1-infected population
Authors:
C T Solem, S J Snedecor, A Khachatryan, K Nedrow, M Tawadrous, R Chambers, S Haider, K Simpson
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis
Authors:
C Howlett, S J Snedecor, D J Landsburg, J Svoboda, E A Chong, S J Schuster, S D Nasta, T Feldman, A Rago, K M Walsh, S Weber, A Goy, A Mato
Economic burden of atopic dermatitis in high-risk infants receiving cow’s milk or partially hydrolyzed 100% whey-based formula
Authors:
A Bhanegaonkar, E G Horodniceanu, X Ji, P Detzel, M Boguniewicz, S Chamlin, A Lake, L A Czerkies, M F Botteman, J M Saavedra
Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants
Authors:
A J Bhanegaonkar, E G Horodniceanu, A H Abdul Latiff, S Woodhull, P C Khoo, P Detzel, X Ji, M F Botteman
Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain.
Authors:
Y Wan, S Corman, X Gao, S Liu, H Patel, R Mody
Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.
Authors:
C J Langer, V Hirsh, I Okamoto, F J Lin, Y Wan, S Whiting, T J Ong, M F Renschler, M F Botteman
Cost-effectiveness analysis of rivaroxaban in the secondary prevention of acute coronary syndromes in Sweden
Authors:
N Begum, S Stephens, O Schoeman, A Fraschke, B Kirsch, J B Briere, F W Verheugt, B van Hout
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections
Authors:
M Dryden, M Baguneid, C Eckmann, S Corman, J Stephens, C Solem, J Li, C Charbonneau, N Baillon-Plot, S Haider
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
Authors:
Y Wan, S X Sun, S Corman, X Huang, X Gao, A F Shorr
Continuous patient engagement in cardiovascular disease clinical comparative effectiveness research
Authors:
J Vandigo, E Oloyede, A Aly, A L Laird, C E Cooke, C D Mullins
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
Authors:
C Bennison, S Stephens, B Lescrauwaet, B Van Hout, T L Jackson
Budget impact of perampanel as adjunctive treatment of uncontrolled partial-onset and primary generalized tonic-clonic seizures in the United States
Authors:
G Tremblay, V Barghout, V Patel, W Tsong, Z Wang
Disease burden of systemic light-chain amyloidosis: a systematic literature review
Authors:
H M Lin, X Gao, C E Cooke, D Berg, R Labotka, D V Faller, B Seal, P Hari
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service
Authors:
KY Westerhout; W Bouwmeester; I Duchesne; M Pisini; MA Piena; F Damele; B Gueron; M Treur; J Belsey
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis
Authors:
U Pelzer, JF Blanc, D Melisi, A Cubillo, D D Von Hoff, A Wang-Gillam, L T Chen, J T Siveke, Y Wan, C T Solem, M F Botteman, Y Yang, F A de Jong, R A Hubner
The importance of economic perspective and quantitative approaches in oncology value frameworks of drug selection and shared decision making
Authors:
A R Waldeck, M F Botteman, R E White, B A van Hout
Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
Authors:
T Wilke, S Mueller, S C Lee, I Majer, M Heisen
Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk infants not exclusively breastfed in Singapore
Authors:
M F Botteman, A J Bhanegaonkar, E G Horodnieanu, X Ji, B W Lee, L P Shek, H P van Bever, P Detzel
Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
Authors:
H H Schmidt, M Waddington-Cruz, M F Botteman, J A Carter, A S Chopra, M M Hopps, M Stewart, S Fallet, L Amass
Systematic review and benchmarking of Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) in oncology
Authors:
C T Solem, Y Kwon, R Shah, A. Aly, M F Botteman
View older
Scroll to top